Evaluation of neoadjuvant therapy by Nematode-NOSE(N-NOSE) using C. elegans

ABSTRACT: Primary outcome(s): ROC-ACU for IRC (chemotaxix index reduction score)

DISEASE(S): Esopahgeal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer

PROVIDER: 2656125 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR